TRX4 is a monoclonal antibody that binds to a receptor found on all T cells called CD3, which is involved in normal T cell signaling. TRX4 is believed to inhibit the function of autoreactive T cells, which are important in propagating autoimmune diseases, while inducing regulatory T cell pathways that promote immunological tolerance and inhibit autoreactive disease activity. Tolerx is developing TRX4 to treat patients with type 1 diabetes, psoriasis and other autoimmune diseases such as rheumatoid arthritis.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-0416CL | Anti-Human CD3 Recombinant Antibody (OKT3) | FC, IB, ELISA | |
TAB-0422CL | Mouse Anti-CD3 Recombinant Antibody (TAB-0422CL) | ELISA | Mouse IgG |
TAB-0416CL-S(P) | Anti-Human CD3 Recombinant Antibody scFv Fragment (OKT3) | IB, ELISA, FC, FuncS | |
TAB-0422CL-S(P) | Mouse Anti-CD3 Recombinant Antibody; scFv Fragment (TAB-0422CL-S(P)) | ELISA | Mouse scFv |
TAB-070LC-F(E) | Mouse Anti-CD3 Recombinant Antibody; Fab Fragment (TAB-070LC-F(E)) | ELISA | Mouse Fab |
There are currently no Customer reviews or questions for Gly-002CL. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.